SRx Health Solutions, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Is SRx Health Solutions, Inc. overvalued or undervalued?

20-Sep-2025

As of August 11, 2025, SRx Health Solutions, Inc. is considered undervalued with an attractive valuation grade despite a significant year-to-date stock decline of -85.57%, highlighted by its negative P/E ratio of -2.6224 and EV to EBITDA of -2.6667 compared to industry peers.

Is SRx Health Solutions, Inc. technically bullish or bearish?

20-Sep-2025

As of October 1, 2023, SRx Health Solutions, Inc. has a bearish technical stance with mixed signals across time frames, underperforming the S&P 500 significantly with year-to-date and one-year returns of -85.57% and -86.39%, respectively.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 12 Million (Micro Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.02

Return on Equity

-999,999.00%

Price to Book

1.48

Revenue and Profits:

Net Sales:

7 Million

(Quarterly Results - Mar 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

17.33%

6 Months

-32.1%

1 Year

-78.85%

2 Years

-97.26%

3 Years

-98.54%

4 Years

-99.7%

5 Years

-99.83%

SRx Health Solutions, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is SRx Health Solutions, Inc. technically bullish or bearish?

As of 1 October 2023, the technical stance for SRx Health Solutions, Inc. is bearish, with a weak strength indicated by mixed signals across various time frames. The weekly MACD is mildly bullish, but the monthly MACD is also mildly bullish, while the RSI shows a bullish signal on the monthly but no signal on the weekly. However, the Bollinger Bands indicate a mildly bearish stance on the weekly and bearish on the monthly. The daily moving averages are bearish, and Dow Theory shows a bearish trend on the weekly with no trend on the monthly. Overall, the indicators suggest a lack of strong bullish momentum. In terms of performance, SRx Health Solutions has significantly underperformed against the S&P 500, with a year-to-date return of -85.57% compared to the S&P 500's 12.22%, and a one-year return of -86.39% versus the S&P 500's 17.14%....

Is SRx Health Solutions, Inc. overvalued or undervalued?

As of 11 August 2025, the valuation grade for SRx Health Solutions, Inc. moved from fair to attractive, indicating a more favorable assessment of its value. The company appears to be undervalued, especially when considering its P/E ratio of -2.6224 and EV to EBITDA of -2.6667, which are significantly lower than typical industry metrics. In comparison to peers, SRx Health Solutions stands out with its negative P/E ratio, while other companies in the pharmaceuticals and biotechnology sector may show more robust valuations. Despite the attractive grade, the company has faced substantial declines in stock performance, with a year-to-date return of -85.57% compared to the S&P 500's 12.22%, highlighting the challenges it faces in the market....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

7.14%

EBIT Growth (5y)

13.50%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

EV to EBITDA

EV to Capital Employed

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 0.00% vs -36.84% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 33.33% vs -200.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.20",
          "val2": "7.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.10",
          "val2": "-1.60",
          "chgp": "31.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.00",
          "val2": "-1.50",
          "chgp": "33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-152.00%",
          "val2": "-230.40%",
          "chgp": "7.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -9.33% vs -29.43% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 99.12% vs 41.98% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35.00",
          "val2": "38.60",
          "chgp": "-9.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.80",
          "val2": "-11.00",
          "chgp": "47.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "1.40",
          "chgp": "-64.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.20",
          "val2": "-8.80",
          "chgp": "170.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.20",
          "val2": "-22.80",
          "chgp": "99.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-170.60%",
          "val2": "-327.70%",
          "chgp": "15.71%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ

Mar'25

Dec'24

Change(%)

Net Sales

7.20

Operating Profit (PBDIT) excl Other Income

-1.10

-1.60

31.25%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-1.00

-1.50

33.33%

Operating Profit Margin (Excl OI)

-152.00%

-230.40%

7.84%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2025 is 0.00% vs -36.84% in Dec 2024

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 33.33% vs -200.00% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

35.00

38.60

-9.33%

Operating Profit (PBDIT) excl Other Income

-5.80

-11.00

47.27%

Interest

0.50

1.40

-64.29%

Exceptional Items

6.20

-8.80

170.45%

Consolidate Net Profit

-0.20

-22.80

99.12%

Operating Profit Margin (Excl OI)

-170.60%

-327.70%

15.71%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -9.33% vs -29.43% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 99.12% vs 41.98% in Dec 2023

All Annual Results

Company CV

About

Company Coordinates

Company Details

Tel:

Registrar Details

SRx Health Solutions, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

Is SRx Health Solutions, Inc. overvalued or undervalued?

Watch in Real-Time

Is SRx Health Solutions, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is SRx Health Solutions, Inc. technically bullish or bearish?

Is SRx Health Solutions, Inc. overvalued or undervalued?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About

Company Coordinates